Magnus Gram

Dr. Magnus Gram

Lund University
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2013 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
Magnus GramMagnus Gram
Magnus Gram
SSSnjolaug Sveinsdottir
Snjolaug Sveinsdottir
KRKarsten Ruscher
Karsten Ruscher
Stefan R. HanssonStefan R. Hansson
Stefan R. Hansson
MCMagnus Cinthio
Magnus Cinthio
DLDavid Ley
David Ley
Cerebral intraventricular hemorrhage (IVH) is a major cause of severe neurodevelopmental impairment in preterm infants. To date, no therapy is available that prevents infants from developing serious neurological disability following IVH. Thus, to develop treatment strategies for IVH, it is essential to characterize the initial sequence of molecular events that leads to brain damage. In this study, we investigated extracellular hemoglobin (Hb) as a causal initiator of inflammation in preterm IVH.

2 December 2014 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
Magnus GramMagnus Gram
Magnus Gram
SSSnjolaug Sveinsdottir
Snjolaug Sveinsdottir
MCMagnus Cinthio
Magnus Cinthio
KSKristbjörg Sveinsdottir
Kristbjörg Sveinsdottir
Stefan R. HanssonStefan R. Hansson
Stefan R. Hansson
DLDavid Ley
David Ley
Intraventricular hemorrhage (IVH) with post-hemorrhagic ventricular dilatation (PHVD) is a major cause of neurodevelopmental impairment and mortality in preterm infants. The mechanisms leading to PHVD and brain damage remain largely unknown. The choroid plexus and the ependyma, which constitute an essential part of the blood-brain barrier (BBB), are the first structures to encounter the damaging effects of extravasated blood. The breakdown of the BBB is a critical upstream event leading to brain damage following IVH. In this study we investigated the impact of hemorrhage and hemoglobin (Hb) metabolites on the choroid plexus epithelium. Using a preterm rabbit pup model of IVH, the structural and functional integrity, cellular, inflammatory and oxidative response of the choroid plexus, at 24 and 72 hours following IVH + PHVD, were investigated. In order to further characterize cellular and molecular mechanisms, primary human choroid plexus epithelial cells were exposed to cerebrospinal fluid (CSF) from preterm infants with IVH as well as to Hb-metabolites. Finally, the blocking effects of the Hb-scavenger haptoglobin (Hp) were investigated both in vivo and in vitro. Following IVH + PHVD, an up-regulation of mRNA for the receptor-related genes TLR-4, IL1R1, FAS, the transcription factor NF-Κβ and for the pro-inflammatory and chemotactic effector molecules, IL-1β, TNFα, MCP-1, IL-8, and IL-6 was observed in the choroid plexus at 24 and 72 hours. This was associated with structural disintegration, caspase activation and cell death in the choroid plexus epithelium. In vitro characterization of choroid plexus epithelial cells, following exposure to hemorrhagic CSF and to the Hb-metabolites metHb and heme, displayed apoptotic and necrotic cell death and an up-regulation of receptor-related and inflammatory effector molecules similar to that observed in vivo following IVH + PHVD. Intraventricular injection of the Hb-scavenger Hp in vivo and co-incubation with Hp in vitro reversed or reduced the cellular activation, inflammatory response, structural damage and cell death. Hb-metabolites are important causal initiators of cell death following IVH and removal or scavenging of Hb-metabolites may present an efficient means to reduce the damage to the immature brain following IVH.

15 January 2010 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
Magnus GramMagnus Gram
Magnus Gram
MCMagnus Centlow
Magnus Centlow
SRSigurbjörg Rutardóttir
Sigurbjörg Rutardóttir
ISIréne Stenfors
Iréne Stenfors
JLJörgen Larsson
Jörgen Larsson
BÅBo Åkerström
Bo Åkerström

1 September 2014 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
Bo ÅkerströmBo Åkerström
Bo Åkerström
Magnus GramMagnus Gram
Magnus Gram

3 March 2021 in Frontiers in Physiology
Verified
Journal Article
Open access
JBJesper Bergwik
Jesper Bergwik
Amanda KristianssonAmanda Kristiansson
Amanda Kristiansson
MAMaria Allhorn
Maria Allhorn
Magnus GramMagnus Gram
Magnus Gram
BÅBo Åkerström
Bo Åkerström
α1-microglobulin (A1M) is found in all vertebrates including humans. A1M was, together with retinol-binding protein and β-lactoglobulin, one of the three original lipocalins when the family first was proposed in 1985. A1M is described as an antioxidant and tissue cleaning protein with reductase, heme- and radical-binding activities. These biochemical properties are driven by a strongly electronegative surface-exposed thiol group, C34, on loop 1 of the open end of the lipocalin barrel. A1M has been shown to have protective effects in vitro and in vivo in cell-, organ-, and animal models of oxidative stress-related medical conditions. The gene coding for A1M is unique among lipocalins since it is flanked downstream by four exons coding for another non-lipocalin protein, bikunin, and is consequently named α1-microglobulin-bikunin precursor gene (AMBP). The precursor is cleaved in the Golgi, and A1M and bikunin are secreted from the cell separately. Recent publications have suggested novel physiological roles of A1M in regulation of endoplasmic reticulum activities and erythrocyte homeostasis. This review summarizes the present knowledge of the structure and functions of the lipocalin A1M and presents a current model of its biological role(s).

3 August 2016 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
DLDavid Ley
David Ley
OROlga Romantsik
Olga Romantsik
SVSuvi Vallius
Suvi Vallius
KSKristbjörg Sveinsdóttir
Kristbjörg Sveinsdóttir
SSSnjolaug Sveinsdóttir
Snjolaug Sveinsdóttir
Magnus GramMagnus Gram
Magnus Gram
Severe cerebral intraventricular hemorrhage (IVH) in preterm infants continues to be a major clinical problem, occurring in about 15-20% of very preterm infants. In contrast to other brain lesions the incidence of IVH has not been reduced over the last decade, but actually slightly increased. Currently over 50% of surviving infants develop post-hemorrhagic ventricular dilatation and about 35% develop severe neurological impairment, mainly cerebral palsy and intellectual disability. To date there is no therapy available to prevent infants from developing either hydrocephalus or serious neurological disability. It is known that blood rapidly accumulates within the ventricles following IVH and this leads to disruption of normal anatomy and increased local pressure. However, the molecular mechanisms causing brain injury following IVH are incompletely understood. We propose that extracellular hemoglobin is central in the pathophysiology of periventricular white matter damage following IVH. Using a preterm rabbit pup model of IVH the distribution of extracellular hemoglobin was characterized at 72 hours following hemorrhage. Evaluation of histology, histochemistry, hemoglobin immunolabeling and scanning electron microscopy revealed presence of extensive amounts of extracellular hemoglobin, i.e. not retained within erythrocytes, in the periventricular white matter, widely distributed throughout the brain. Furthermore, double immunolabeling together with the migration and differentiation markers polysialic acid neural cell adhesion molecule (PSA-NCAM) demonstrates that a significant proportion of the extracellular hemoglobin is distributed in areas of the periventricular white matter with high extracellular plasticity. In conclusion, these findings support that extracellular hemoglobin may contribute to the pathophysiological processes that cause irreversible damage to the immature brain following IVH.